AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Refnil D 30mg/20mg Capsule SR

Prescription Icon
Prescription Required

Marketer

Athens Labs Ltd

Salt Composition

Domperidone (30mg) + Rabeprazole (20mg)

Overview Refnil D 30mg/20mg Capsule SR

Gastro-esophageal reflux disease (GERD), or acid reflux, can be managed with Refnil D 30mg/20mg SR capsules, a dual-action formulation. This medication alleviates acid reflux symptoms like heartburn, stomach upset, and irritation by neutralizing stomach acid and facilitating gas expulsion. Refnil D 30mg/20mg SR capsules should be taken on an empty stomach, following your physician's prescribed dosage and duration. Treatment length depends on individual response and condition severity; premature discontinuation may lead to symptom recurrence and disease exacerbation. Inform your doctor of all other medications you're using, as interactions are possible. Common, typically transient side effects include diarrhea, abdominal pain, dry mouth, headache, gas, and fatigue. Report any concerning side effects immediately. Drowsiness and dizziness are potential side effects; refrain from driving or activities requiring alertness until the medication's impact is understood. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle adjustments, such as consuming cold milk and avoiding hot beverages, spicy foods, and chocolate, may enhance treatment efficacy. Prior to commencing treatment, disclose any kidney or liver conditions, pregnancy, pregnancy plans, or breastfeeding to your doctor.

Uses of Refnil D 30mg/20mg Capsule SR

Managing gastroesophageal reflux and peptic ulcers.

Major Benefits of Refnil D 30mg/20mg Capsule SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the capsule whole; avoid chewing, crushing, or breaking it. Administer Refnil D 30mg/20mg SR Capsules on an empty stomach.

Common Side effects of Refnil D 30mg/20mg Capsule SR:

  • Cough
  • Headache
  • Diarrhea
  • Dizziness
  • Inflammation of the nose
  • Abdominal pain
  • Vomiting
  • Weakness
  • Nasal congestion (stuffy nose)
  • Insomnia (difficulty in sleeping)
  • Fundic gland polyps
  • Nausea
  • Constipation
  • Flatulence
  • Back pain
  • Pharyngitis

How to use Refnil D 30mg/20mg Capsule SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the entire capsule without chewing, crushing, or breaking it. Refnil D 30mg/20mg Extended-Release Capsules should be taken on an empty stomach.

How Refnil D 30mg/20mg Capsule SR works:

Refnil D SR capsules, containing 30mg Domperidone and 20mg Rabeprazole, offer dual-action relief. Domperidone, a prokinetic agent, enhances gastrointestinal motility, facilitating smoother food passage. Rabeprazole, a proton pump inhibitor (PPI), decreases stomach acid production, providing relief from heartburn and acid indigestion.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when using Refnil D 30mg/20mg SR capsules with alcohol. Seek medical advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Refnil D capsules (30mg/20mg) may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The prolonged-release Refnil D 30mg/20mg capsule is likely unsuitable for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Refnil D 30mg/20mg sustained-release capsules might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Exercise caution when administering Refnil D 30mg/20mg SR capsules to individuals with impaired renal function. Dosage modification for Refnil D 30mg/20mg SR capsules may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Refnil D 30mg/20mg SR capsules; dosage modification may be necessary. Consult a physician for guidance. Refnil D 30mg/20mg SR capsules are contraindicated in individuals with moderate to severe hepatic dysfunction.

What if you forget to take Refnil D 30mg/20mg Capsule SR :

Should you forget to take a Refnil D 30mg/20mg Capsule SR, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Refnil D 30mg/20mg Capsule SR

LabelValue
Potential for Dependence None.
Type of Treatment Gastrointestinal system

FAQs on Refnil D 30mg/20mg Capsule SR

Refnil D 30mg/20mg sustained-release capsules contain domperidone and rabeprazole. This dual-action formulation addresses acidity, heartburn, and gastroesophageal reflux disease (GERD), a condition characterized by stomach acid reflux into the esophagus. It's also indicated for gastric and duodenal ulcers. Domperidone's mechanism of action involves enhancing gut motility, thus facilitating efficient gastric emptying and mitigating vomiting.
Refnil D 30mg/20mg sustained-release capsules are contraindicated in individuals with documented hypersensitivity to rabeprazole, domperidone, or any excipients within the formulation. Patients with pre-existing hepatic or renal impairment require careful monitoring.
Indeed, taking Refnil D 30mg/20mg sustained-release capsules may lead to xerostomia. This side effect is attributed to the domperidone component. To alleviate dry mouth, increase your fluid intake. Keeping water readily available overnight is advisable. Reducing alcohol consumption and abstaining from smoking are also recommended. Should dry mouth persist, opt for alcohol-free mouthwash to mitigate the potential for dental caries.
Diarrhea is a potential side effect of Refnil D 30mg/20mg SR capsules. If diarrhea occurs, increase your fluid intake. Restrict consumption of greasy or deep-fried foods while taking this medication. Consult your physician if diarrhea continues or you observe dehydration symptoms such as reduced urination and dark, concentrated urine.
Maintain this medication within its original, securely sealed container. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and others.
Refnil D 30mg/20mg sustained-release capsules are generally well-tolerated. Nevertheless, some individuals may experience typical side effects such as abdominal discomfort, flatulence, dry mouth, vertigo, cephalalgia, or diarrhea. Less frequent or infrequent adverse reactions are also possible. Report any ongoing issues to your physician during treatment.
Optimal administration of Refnil D 30mg/20mg sustained-release capsules is before the initial meal or while fasting.
Taking Refnil D 30mg/20mg Capsule SR may elevate the likelihood of experiencing an abnormal heart rhythm (severe arrhythmias). While a serious potential side effect, the probability of this occurring is quite small. However, individuals over 60 years old might face a marginally increased risk.
Refnil D 30mg/20mg sustained-release capsules contain domperidone and rabeprazole. This formulation addresses heartburn, acid reflux (GERD—gastroesophageal reflux disease), where stomach acid rises into the esophagus, and also treats gastric and duodenal ulcers. Domperidone's action on gut motility facilitates improved food transit through the stomach, thus mitigating vomiting.
Patients with hypersensitivity to rabeprazole, domperidone, or any excipient in Refnil D 30mg/20mg SR Capsules should avoid its use. Individuals with pre-existing hepatic or renal impairment require careful monitoring when considering this medication.
Indeed, taking Refnil D 30mg/20mg SR capsules may lead to xerostomia. This side effect is attributed to the Domperidone component. To alleviate dry mouth, increase your fluid intake. Keep a water source nearby, especially overnight. Reduce alcohol consumption and refrain from smoking. For dry mouth relief, consider alcohol-free mouthwashes to minimize the potential for dental caries.
Diarrhea is a potential side effect of Refnil D 30mg/20mg SR Capsules. If diarrhea occurs, increase your fluid intake. Oily or greasy foods should be avoided while taking this medication. Consult your physician if diarrhea continues or if you observe dehydration symptoms such as reduced urination and dark, concentrated urine.
Refnil D 30mg/20mg sustained-release capsules are generally well-tolerated. Nevertheless, some individuals may experience common adverse reactions such as diarrhea, abdominal discomfort, gas, dry mouth, vertigo, and cephalalgia, along with less frequent or infrequent side effects. Report any ongoing issues to your physician during treatment.
Optimal administration of Refnil D 30mg/20mg sustained-release capsules is before the initial meal or while fasting.
Taking Refnil D 30mg/20mg SR capsules may elevate the likelihood of experiencing an abnormal heart rhythm (severe arrhythmias). While a serious potential side effect, the probability of this occurring remains quite small. However, the risk might be marginally greater for individuals over 60.
Maintain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Refnil D 30mg/20mg Capsul...
72
MRP 88
18% off